Search Results 341-350 of 1977 for ⚕보급형 ARP프로토콜 노후투자 확장성이좋다⚕

1. Oral Protocatechuic Acid (PCA) as a Prophylaxis Against C. Acnes Wound Colonization During Total Shoulder Arthroplasty. - Mayo Clinic

   The purpose of this study is to determine whether a preoperative oral course of the nutritional supplement PCA can result in the decrease in C. acnes positive ...

2. Faculty and staff - Genome Function, Stability and Nuclear Organization in Cancer: Veronica Rodriguez-Bravo - Mayo Clinic Research

   See faculty and staff of Mayo Clinic's Genome Function, Stability and Nuclear Organization in Cancer Lab led by Veronica Rodriguez-Bravo, Ph.D.

3. A Study to Enroll Patients of Rheumatic Diseases and First-degree Relatives in a Biobank - Mayo Clinic

   Sponsor Protocol Number: 14-000616. About this study. The purpose of this study is to enroll rheumatic disease patients and first-degree relatives in a ...

4. A Study to Detect Actionable or Predictive Tumor DNA Mutations in Peripheral Blood (Liquid Biopsy) from Patients with Cholangiocarcinoma (CCA) - Mayo Clinic

   The purpose of this study is to investigate the feasibility of isolating circulating tumor cells (CTCs) and cfDNA from patients with CCA for molecular ...

5. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

6. Patient Transfer Tray Usability and Biomechanical Assessment - Mayo Clinic

   The purpose of this project is to perform a biomechanical and usability analyses of a patient transfer tray for horizontally transporting patients to and from ...

7. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

   Sponsor Protocol Number: GED-0301-CD-004. About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 ...

8. Intrathecally Administered Gene Therapy APB-102 in Rapidly Progressive ALS Patients with SOD1 Mutations - Mayo Clinic

   This is a Phase 1/2 open-label, multicenter study to evaluate the safety and tolerability and to explore the efficacy of gene therapy AMT-162 in Participants ...

9. A Study to Evaluate Ulixertinib to Treat Patients with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations - Mayo Clinic

   Early clinical data have demonstrated anti-tumor activity with ulixertinib treatment and have identified specific groups of patients for whom additional ...

10. A Study of Patient Centered Approaches to Gene Editing - Mayo Clinic

    The purpose of this study is to elicit lay, lived experience, and experts' ethical concerns, clinical aspirations and governance needs regarding prenatal gene ...